Publicaciones en las que colabora con Carlos Alonso Moreno (6)

2024

  1. Antitumoral activity of a CDK12 inhibitor in colorectal cancer through a liposomal formulation

    Biomedicine and Pharmacotherapy, Vol. 178

2023

  1. Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Clinical considerations for the design of PROTACs in cancer

    Molecular Cancer, Vol. 21, Núm. 1

2019

  1. Poly(Cyclohexene phthalate) nanoparticles for controlled dasatinib delivery in breast cancer therapy

    Nanomaterials, Vol. 9, Núm. 9

  2. Screening and preliminary biochemical and biological studies of [RuCl(p-cymene)(N, N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models

    ACS Omega, Vol. 4, Núm. 8, pp. 13005-13014

  3. Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer

    Nanomaterials, Vol. 9, Núm. 12